Event overview
Drug Companies Spurned by Supreme Court on Price Negotiation Law
The US Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Medicare drug price negotiation program that’s led to billions of dollars in discounts on top-selling treatments. This cluster currently includes 2 articles from 2 sources.
This cluster currently includes 2 articles from 2 sources. Sources in this event include PBS NewsHour, Bloomberg.
Left / left-center
2
Center
0
Right / right-center
0
Drug Companies Spurned by Supreme Court on Price Negotiation Law
The US Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Medicare drug price negotiation program that’s led to billions of dollars in discounts on top-selling treatments.
Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations with government
Mark Sherman, Associated Press Mark Sherman, Associated Press Ali Swenson, Associated Press Ali Swenson, Associated Press WASHINGTON (AP) — The Supreme Court on Monday rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government. The justices did not.